ArticleBMJ open2025

Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.

Robert Durcan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.